Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age20+
SponsorTakeshi Morimoto
About this trial
The purpose of this study is to evaluate the efficacy and safety aspirin in patients with chronic coronary syndromes without revascularization.
Eligibility criteria
Qualifiers
Patients with chronic coronary syndromes with ≧50% diameter stenosis in one or more major coronary vessels/major branches on coronary CT or coronary angiography but not eligible for coronary revascularization
Patients for whom consent can be obtained
Disqualifiers
Patients with history of acute coronary syndromes (ACS)
Patients with history of percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG)
Patients with left main trunk stenosis (≥50%)
Patients for whom aspirin administration is mandatory
Trial design
Treatments tested in this trial
- Aspirin
- No aspirin
Treatment groups
2,890 Participants
are divided into 2 treatment groupsSponsors and collaborators
Takeshi Morimoto
Lead sponsor
Kyoto University, Graduate School of Medicine
Sponsor institution
Source ClinicalTrials.gov